Skip to main content

Table 3 Average costs of genital herpes per patient in first and recurrent episodes

From: The estimated economic burden of genital herpes in the United States. An analysis using two costing approaches

 

First episode

%

% of total

Recurrent episode

%

% of total

Medical costs

      

Consultations

62.6

35.8%

 

59.6

47.3%

 

Clinical examination

39.8

22.7%

 

36.2

28.7%

 

Microbiologic tests

17.6

10.1%

 

6.7

5.3%

 

Antibody testing

12.8

7.3%

 

6.5

5.2%

 

Complete blood count

4.6

2.6%

 

1.5

1.2%

 

Urine analysis

4.6

2.6%

 

3.2

2.5%

 

Others

33.0

18.9%

 

12.3

9.8%

 

Total

175.0

100%

58.3%

126.0

100%

38.8%

Drug treatment

      

Antiviral treatment

64.0

100%

 

131.0

100%

 

Total

64.0

100%

21.3%

131.0

100%

40.3%

Hospital

      

Hospitalization

1.0

 

0.4%

8.0

 

2.4%

Total direct costs

240.0

 

80.0%

265.0

 

81.5%

Indirect costs

      

Production losses

60.0

 

20.0%

60.0

 

18.5%

Total costs per patient

300.0

 

100%

325.0

 

100%

  1. Note: Costs are expressed in 1996 US$.